Sensorion’s sudden sensorineural hearing loss asset fails Phase II test
The asset failed to meet the primary goal of 15 decibels, a substantial improvement in pure tone audiometry in the…
Ear Nose Throat Disorders
Latest in
Ear Nose Throat Disorders
Frequency’s Phase IIa hearing loss trial shows no benefit versus placebo
Day-90 data from a Phase IIa study of four dosing regimens of Frequency Therapeutics’ hearing loss treatment FX-322 in subjects…
By
Sensorion gets approval to add new sites to Phase II trial of SENS-401
Biotech firm Sensorion has received approval from the Independent Ethics Committee of Strasbourg in France to add new military sites…
Bellus Health starts recruitment in Phase II chronic cough trial
Canadian biopharmaceutical firm Bellus Health has commenced patient enrolment in the Phase II RELIEF clinical trial of BLU-5937 to treat…